
Two Playbooks: Go Broad or Go Niche — Who Wins? | Tempus AI vs. Valar Labs
Two companies chasing the same mission — getting the right cancer treatment to the right patient — with two completely opposite playbooks. One raised $1.3 billion to build an empire. The other ships FDA-recognized diagno



























